Dai ichi Life Insurance Company Ltd acquired a new stake in shares of TransUnion (NYSE:TRU – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 6,563 shares of the business services provider’s stock, valued at approximately $687,000.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Massachusetts Financial Services Co. MA boosted its stake in TransUnion by 32.2% during the second quarter. Massachusetts Financial Services Co. MA now owns 16,339,762 shares of the business services provider’s stock worth $1,211,757,000 after buying an additional 3,977,595 shares in the last quarter. XN LP boosted its position in shares of TransUnion by 194.7% during the 2nd quarter. XN LP now owns 1,973,684 shares of the business services provider’s stock valued at $146,368,000 after acquiring an additional 1,303,996 shares in the last quarter. Westfield Capital Management Co. LP bought a new stake in TransUnion in the third quarter valued at about $92,661,000. Ninety One UK Ltd raised its position in TransUnion by 37.4% in the second quarter. Ninety One UK Ltd now owns 2,566,928 shares of the business services provider’s stock worth $190,363,000 after purchasing an additional 698,580 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in TransUnion by 24.1% during the second quarter. Victory Capital Management Inc. now owns 3,468,854 shares of the business services provider’s stock worth $257,250,000 after purchasing an additional 674,187 shares during the period.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on TRU. Oppenheimer lowered their price objective on TransUnion from $122.00 to $115.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. Needham & Company LLC reiterated a “hold” rating on shares of TransUnion in a research note on Thursday, October 24th. Morgan Stanley lifted their price objective on TransUnion from $103.00 to $119.00 and gave the company an “overweight” rating in a report on Thursday, October 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $121.00 target price on shares of TransUnion in a report on Thursday, October 24th. Finally, Wells Fargo & Company lifted their price target on shares of TransUnion from $125.00 to $135.00 and gave the company an “overweight” rating in a report on Thursday, October 24th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, TransUnion currently has a consensus rating of “Moderate Buy” and a consensus target price of $106.38.
Insider Activity at TransUnion
In other TransUnion news, Director George M. Awad sold 12,000 shares of the company’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $100.00, for a total transaction of $1,200,000.00. Following the completion of the sale, the director now owns 27,026 shares in the company, valued at approximately $2,702,600. The trade was a 30.75 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Timothy J. Martin sold 2,500 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $95.65, for a total value of $239,125.00. Following the completion of the transaction, the executive vice president now owns 49,239 shares in the company, valued at $4,709,710.35. This represents a 4.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 19,500 shares of company stock worth $1,954,740 over the last ninety days. Company insiders own 0.28% of the company’s stock.
TransUnion Stock Up 0.3 %
NYSE:TRU opened at $101.00 on Friday. The company has a market cap of $19.68 billion, a price-to-earnings ratio of 87.83, a P/E/G ratio of 1.42 and a beta of 1.62. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.68 and a current ratio of 1.68. The stock’s fifty day moving average price is $103.70 and its two-hundred day moving average price is $90.18. TransUnion has a 52-week low of $56.85 and a 52-week high of $113.17.
TransUnion (NYSE:TRU – Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The business services provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.03. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. TransUnion had a return on equity of 15.38% and a net margin of 5.47%. The firm’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.80 earnings per share. On average, analysts anticipate that TransUnion will post 3.45 EPS for the current year.
TransUnion Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 9th. Investors of record on Friday, November 22nd will be paid a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date is Friday, November 22nd. TransUnion’s dividend payout ratio (DPR) is 36.52%.
TransUnion Company Profile
TransUnion operates as a global consumer credit reporting agency that provides risk and information solutions. The company operates through U.S. Markets, International, and Consumer Interactive segments. The U.S. Markets segment provides consumer reports, actionable insights, and analytic services to businesses, which uses its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Recommended Stories
- Five stocks we like better than TransUnion
- How to invest in marijuana stocks in 7 stepsĀ
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Health Care Stocks Explained: Why You Might Want to Invest
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding TRU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TransUnion (NYSE:TRU – Free Report).
Receive News & Ratings for TransUnion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransUnion and related companies with MarketBeat.com's FREE daily email newsletter.